Bentham is offering subject-based scholarly content collections which are tailored to meet specific research needs. Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles as soon as they are published and added to these collections. With new articles being added to these collections on a daily basis, the collections serve as an ideal tool to keep researchers updated with new developments in the respective fields.
DOI: 10.2174/97898150400431220201 eISBN: 978-981-5040-04-3, 2022 ISBN: 978-981-5040-05-0
Back Recommend this Book to your Library Cite as
Cite this Book as:
For Books Rajesh Kumar Singh , " Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II ", Bentham Science Publishers (2022). https://doi.org/10.2174/97898150400431220201
Print ISBN978-981-5040-05-0
Online ISBN978-981-5040-04-3
Page: i-i (1) Author: Roman Lesyk DOI: 10.2174/9789815040043122020001
Page: ii-iii (2) Author: Rajesh Kumar Singh DOI: 10.2174/9789815040043122020002
Page: iv-iv (1) Author: DOI: 10.2174/9789815040043122020003
Page: 1-34 (34) Author: Shweta Sharma, Mymoona Akhter and Rajesh Kumar Singh* DOI: 10.2174/9789815040043122020004 PDF Price: $15
Page: 35-78 (44) Author: Rohit Bhatia, Amandeep Singh, Bhupinder Kumar and Ravindra K. Rawal* DOI: 10.2174/9789815040043122020005 PDF Price: $15
Page: 79-104 (26) Author: Preeti Koli and Rajesh K. Singh* DOI: 10.2174/9789815040043122020006 PDF Price: $15
Page: 105-136 (32) Author: Ashwani K. Dhingra*, Bhawna Chopra, Akram Sidhu, Kumar Guarve and Ashish Gupta DOI: 10.2174/9789815040043122020007 PDF Price: $15
Page: 137-173 (37) Author: Archana Kumari and Rajesh K. Singh* DOI: 10.2174/9789815040043122020008 PDF Price: $15
Page: 174-207 (34) Author: Anurag Chaudhary, Kalpana Singh, Nishant Verma and Alok Sharma* DOI: 10.2174/9789815040043122020009 PDF Price: $15
Page: 208-218 (11) Author: Rajesh Kumar Singh DOI: 10.2174/9789815040043122020010
This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in pharmaceutical chemistry and are written to give a general overview of the topic to readers involved in all levels of research and decision-making in pharmaceutical chemistry and anti-cancer drug design. Part II of the book set covers these topics: - Anticancer targets for heterocyclic lead compounds - Coumarin hybrids for cancer treatments - Progress in nitrogen and sulphur-based heterocyclic compounds for their anticancer activity - Imidazole as an anticancer heterocyclic ring - Morpholine for profiling anticancer lead compounds - Natural products as anticancer agents
Drug Delivery Letters
Recent Advances in Anti-Infective Drug Discovery
Applied Drug Research, Clinical Trials and Regulatory Affairs
Current Bioactive Compounds
Current Drug Delivery
Current Drug Safety
Drug Metabolism and Bioanalysis Letters
Recent Advances in Drug Delivery and Formulation
Reviews on Recent Clinical Trials
Current Drug Targets - Inflammation & Allergy
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Chemoinformatics: Directions Toward Combating Neglected Diseases
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms